Journal article
Development of the IRIS-AR strategy: an intervention to improve rates of accrual and retention for the VTE-PRO randomized controlled trial
Abstract
BackgroundThe Venous Thromboembolism Prophylaxis (VTE-PRO) randomized trial is a pilot study evaluating the impact of extended-duration prophylaxis on venous thromboembolic events in patients undergoing lung cancer resection. Enrolled VTE-PRO participants self-inject either low-molecular weight heparin or a saline placebo for 30 days postoperatively. Study outcomes include feasibility, incidence of venous thromboembolism, and venous …
Authors
Fahim C; Hylton D; Simunovic M; Agzarian J; Finley C; Hanna WC; Shargall Y
Journal
Trials, Vol. 20, No. 1,
Publisher
Springer Nature
Publication Date
December 2019
DOI
10.1186/s13063-019-3536-8
ISSN
1468-6708
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AnticoagulantsChoice BehaviorDrug Administration ScheduleHealth Knowledge, Attitudes, PracticeHeparin, Low-Molecular-WeightHumansInjectionsLung NeoplasmsPatient Education as TopicPatient SelectionPilot ProjectsPneumonectomyResearch SubjectsSample SizeSelf AdministrationTime FactorsTreatment OutcomeVenous Thromboembolism